NCL Method GTA-11
Autophagic Dysfunction Assay: Qualitative Analysis of MAP LC3-I to LC3-II Conversion By Western Blot
Listed in Datasets | publication by group NCL Protocols
Version 2.0 - published on 09 Jul 2020 doi:10.17917/WY7Z-MD10 - cite this
Licensed under these terms
Lysosomal dysfunction is recognized as a potential toxic mechanism for xenobiotics that can result in various pathological states (1). There is concern that nanoparticles, in particular, may cause lysosomal pathologies, since they are likely to accumulate within lysosomes (2). Lysosomal dysfunction could potentially result from nanoparticle biopersistance, or inhibition of lysosomal enzymes, such as inhibition of phospholipase resulting in phospholipidosis, or inhibition of lysosomal protein degradation resulting in lysosomal overload (1). Possibly related to lysosomal dysfunction, nanoparticle exposure has also been shown to cause autophagic dysfunction (3), resulting in accumulation of autophagic vacuoles. Common methods used to detect autophagic dysfunction include microscopy and protein modification assays, such as microtubule associated protein light chain 3-I (MAP LC3-I) lipidation (4).
- NCL_Method_GTA-11.pdf(PDF | 743 KB)
Cite this work
Researchers should cite this work as follows:
- Stephan Stern, Chris McLeland, Jamie Rodriguez (2020). NCL Method GTA-11. (Version 2.0). NCI Hub. doi:10.17917/WY7Z-MD10
Relation to series
The publication is part of the series below:
Analytics Data (TEST)
Test publication based on site analytics
This publication belongs to the NCL Protocols group.
When watching a publication, you will be notified when a new version is released.